CorrellC, ManuP, OlshanskiyV, NapolitanoB, KaneJM, MalhotraAK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA, 302:1765–1773. 2009.
2.
SchimmelmannBG, Mehler-WexC, LambertM, Schulze-zur-WieschC, KochE, Henning FlechtneH, GierowB, MaierJ, MeyerE, Schulte-MarkwortM. A prospective 12 week study of quetiapine in adolescents with schizophrenia spectrum disorder. J Child Adolesc Psychopharmcol, 17:768–778. 2007.
